Clinical Management in Multiple Sclerosis
This review aims to provide a comprehensive overview of the main types, subtypes, clinical manifestations, and current therapeutic strategies for multiple sclerosis, emphasizing recent advancements and clinical challenges. Multiple Sclerosis (MS) is a demyelinating, chronic, autoimmune, and inflamma...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Neuroglia |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2571-6980/6/1/6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849343116103909376 |
|---|---|
| author | Ana Victoria Arredondo-Robles Karen Paola Rodríguez-López Rodolfo Daniel Ávila-Avilés |
| author_facet | Ana Victoria Arredondo-Robles Karen Paola Rodríguez-López Rodolfo Daniel Ávila-Avilés |
| author_sort | Ana Victoria Arredondo-Robles |
| collection | DOAJ |
| description | This review aims to provide a comprehensive overview of the main types, subtypes, clinical manifestations, and current therapeutic strategies for multiple sclerosis, emphasizing recent advancements and clinical challenges. Multiple Sclerosis (MS) is a demyelinating, chronic, autoimmune, and inflammatory disease that affects the Central Nervous System (CNS). Its classification has the following subtypes: Relapsing-Remitting (RRMS), Secondary-Progressive (SPMS), and Primary-Progressive (PPMS), including rarer subtypes such as Clinically Isolated Syndrome (CIS), Radiologically Isolated Syndrome (RIS), Balo’s Concentric Sclerosis (BCS), Schilder’s Disease (SD), and Progressive-Relapsing MS (PRMS). This article divides the various treatments for MS into the following three categories: acute relapse management, symptomatic treatments, and Disease-Modifying Treatments (DMTs). The latter represents revolutionary research in MS, since they are the drugs considered as the best treatment alternatives for this disease. |
| format | Article |
| id | doaj-art-eaecb97fea404b808a4f3b8b7b1c01bf |
| institution | Kabale University |
| issn | 2571-6980 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Neuroglia |
| spelling | doaj-art-eaecb97fea404b808a4f3b8b7b1c01bf2025-08-20T03:43:10ZengMDPI AGNeuroglia2571-69802025-02-0161610.3390/neuroglia6010006Clinical Management in Multiple SclerosisAna Victoria Arredondo-Robles0Karen Paola Rodríguez-López1Rodolfo Daniel Ávila-Avilés2Centro de Investigación y Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), Mexico City C.P. 07360, MexicoFacultad de Ciencias, Universidad Autónoma del Estado de México, Piedras Blancas, Carretera Toluca Kilómetro 15.5, Ixtlahuaca de Rayón C.P. 50200, Estado de Mexico, MexicoCentro de Investigación y Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), Mexico City C.P. 07360, MexicoThis review aims to provide a comprehensive overview of the main types, subtypes, clinical manifestations, and current therapeutic strategies for multiple sclerosis, emphasizing recent advancements and clinical challenges. Multiple Sclerosis (MS) is a demyelinating, chronic, autoimmune, and inflammatory disease that affects the Central Nervous System (CNS). Its classification has the following subtypes: Relapsing-Remitting (RRMS), Secondary-Progressive (SPMS), and Primary-Progressive (PPMS), including rarer subtypes such as Clinically Isolated Syndrome (CIS), Radiologically Isolated Syndrome (RIS), Balo’s Concentric Sclerosis (BCS), Schilder’s Disease (SD), and Progressive-Relapsing MS (PRMS). This article divides the various treatments for MS into the following three categories: acute relapse management, symptomatic treatments, and Disease-Modifying Treatments (DMTs). The latter represents revolutionary research in MS, since they are the drugs considered as the best treatment alternatives for this disease.https://www.mdpi.com/2571-6980/6/1/6Multiple Sclerosis (MS)relapsessymptomatic problemsdisease-modifying therapy |
| spellingShingle | Ana Victoria Arredondo-Robles Karen Paola Rodríguez-López Rodolfo Daniel Ávila-Avilés Clinical Management in Multiple Sclerosis Neuroglia Multiple Sclerosis (MS) relapses symptomatic problems disease-modifying therapy |
| title | Clinical Management in Multiple Sclerosis |
| title_full | Clinical Management in Multiple Sclerosis |
| title_fullStr | Clinical Management in Multiple Sclerosis |
| title_full_unstemmed | Clinical Management in Multiple Sclerosis |
| title_short | Clinical Management in Multiple Sclerosis |
| title_sort | clinical management in multiple sclerosis |
| topic | Multiple Sclerosis (MS) relapses symptomatic problems disease-modifying therapy |
| url | https://www.mdpi.com/2571-6980/6/1/6 |
| work_keys_str_mv | AT anavictoriaarredondorobles clinicalmanagementinmultiplesclerosis AT karenpaolarodriguezlopez clinicalmanagementinmultiplesclerosis AT rodolfodanielavilaaviles clinicalmanagementinmultiplesclerosis |